COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 1805: Articles 18041-18050  | Next

A Second Wave? What Do People Mean By COVID Waves?- A Working Definition of Epidemic Waves
Zhang, S. X., Arroyo Marioli, F., Gao, R.
10.1101/2021.02.21.21252147 — Posted: 2021-02-23
Rapid SARS-CoV-2 variants spread detected in France using specific RT-PCR testing
Haim-Boukobza, S., Trombert-Paolantoni, S., Roquebert, B., Lecorche, E., Verdurme, L., Foulongne, V., Selinger, C., Michalakis, Y., Sofonea, M. T., Alizon, S.
10.1101/2021.02.20.21251927 — Posted: 2021-02-23
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
Nambulli, S., Xiang, Y., Tilston-Lunel, N. L., Rennick, L. J., Sang, Z., Klimstra, W. B., Reed, D. S., Crossland, N. A., Shi, Y., Duprex, P. W.
10.1101/2021.02.23.432569 — Posted: 2021-02-23
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.
Goswami, R., Russell, V. S., Tu, J. J., Hughes, P., Kelly, F., Langel, S. N., Steppe, J., Palmer, S. M., Haystead, T., Blasi, M., Permar, S. R.
10.1101/2021.02.23.432479 — Posted: 2021-02-23
Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection
Bottino, D., Hather, G., Yuan, L., Stoddard, M., White, L., Chakravarty, A.
10.1101/2021.02.22.432379 — Posted: 2021-02-23 Discussion: Onsite
Structural Basis for SARS-CoV-2 Envelope Protein in Recognition of Human Cell Junction Protein PALS1
Chai, J., Cai, Y., Pang, C., Wang, L., McSweeney, S., Shanklin, J., Liu, Q.
10.1101/2021.02.22.432373 — Posted: 2021-02-23
Metagenomic diagnosis and pathogenic network profile of SARS-CoV-2 in patients co-morbidly affected by type 2 diabetes
Al-Emran, H. M., Rahman, M. S., Hasan, M. S., Alam, A. S. M. R. U., Islam, O. K., Anwar, A., Jahid, I. K., Hossain, M. A.
10.1101/2021.02.23.432535 — Posted: 2021-02-23
Comprehensive evaluation of ACE2 expression in female ovary by single-cell RNA-seq analysis
Kong, S., Yan, Z., Yuan, P., Liu, X., Chen, Y., Yang, M., Chen, W., Song, S., Yan, J., Yan, L., Qiao, J.
10.1101/2021.02.23.432460 — Posted: 2021-02-23
Anti-cardiolipin and other anti-phospholipid antibodies in critically ill COVID-19 positive and negative patients
Trahtemberg, U., Rottapel, R., DosSantos, C., Slutsky, A. S., Baker, A. J., Fritzler, M. J.
10.1101/2021.02.19.21252113 — Posted: 2021-02-23
SARS-Cov-2 testing in the United Arab Emirates: Population Attitudes and Beliefs.
Baynouna AlKetbi, L., Nagelkerke, N., Abdelbaqi, H., ALBlooshi, F., AlSaedi, M., Almansoori, S., AlNuaimi, R., AlKhoori, A., AlAryani, A., Al Jiziri, A., AlMestika, N., AlShamsi, M., Kayani, F., Alblooshi, N., AlKhajeh, S., Al Hammadi, I., AlDhahei, S., AlFalahi, J.
10.1101/2021.02.19.21251841 — Posted: 2021-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).